During the past decade, Hamilton Medical Research Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hamilton Medical Research Group" are "Cytomegalovirus" (1 trials) and "Seasonal Influenza" (1 trials). Many other conditions were trialed in "Hamilton Medical Research Group" in a lesser frequency.

Most popular intervention types in "Hamilton Medical Research Group" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Licensed quadrivalent inactivated seasonal influenza vaccine" (1 trials), "Placebo" (1 trials), "mRNA-1010" (1 trials) and "mRNA-1647" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hamilton Medical Research Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hamilton Medical Research Group". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hamilton Medical Research Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hamilton Medical Research Group, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".